New hope for advanced cancer patients as novel drug trial begins
Disease control
Recruiting now
This early-stage trial is testing a new oral drug called PTT-4256 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also look for early signs t…
Phase: PHASE1, PHASE2 • Sponsor: Pathios Therapeutics Pty Ltd • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC